Cargando…

Safe and efficient lentiviral vector integration with HSC-targeted gene therapy

Detalles Bibliográficos
Autores principales:	Radtke, Stefan, Pande, Dnyanada, Enstrom, Mark, Kiem, Hans-Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480530/ https://www.ncbi.nlm.nih.gov/pubmed/36534128 http://dx.doi.org/10.1182/bloodadvances.2022009087

Ejemplares similares

Purification of Human CD34(+)CD90(+) HSCs Reduces Target Cell Population and Improves Lentiviral Transduction for Gene Therapy
por: Radtke, Stefan, et al.
Publicado: (2020)

Intracellular RNase activity dampens zinc finger nuclease-mediated gene editing in hematopoietic stem and progenitor cells
por: Peterson, Christopher W., et al.
Publicado: (2021)

Safe and Effective Gene Therapy for Murine Wiskott-Aldrich Syndrome Using an Insulated Lentiviral Vector
por: Singh, Swati, et al.
Publicado: (2016)

Abrogated cryptic activation of lentiviral transfer vectors
por: Luche, Ralf M., et al.
Publicado: (2012)

Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5/35++ vectors
por: Li, Chang, et al.
Publicado: (2021)

Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device
por: Olgasi, Cristina, et al.
Publicado: (2021)

In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4
por: Wang, Hongjie, et al.
Publicado: (2022)

The unknown impact of conditioning on HSC engraftment and clonal dynamics
por: Radtke, Stefan
Publicado: (2023)

Intraosseous delivery of platelet-targeted factor VIII lentiviral vector in humanized NBSGW mice
por: Joo, Julia H., et al.
Publicado: (2022)

Integrase deficient lentiviral vector: prospects for safe clinical applications
por: Yew, Chee-Hong Takahiro, et al.
Publicado: (2022)

Isolation of a Highly Purified HSC-enriched CD34(+)CD90(+)CD45RA(−) Cell Subset for Allogeneic Transplantation in the Nonhuman Primate Large-animal Model
por: Radtke, Stefan, et al.
Publicado: (2020)

Efficient gene targeting mediated by a lentiviral vector-associated meganuclease
por: Izmiryan, Araksya, et al.
Publicado: (2011)

The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes
por: Sánchez-Hernández, Sabina, et al.
Publicado: (2018)

Design and Potential of Non-Integrating Lentiviral Vectors
por: Shaw, Aaron, et al.
Publicado: (2014)

Lentiviral Vectors for Ocular Gene Therapy
por: Arsenijevic, Yvan, et al.
Publicado: (2022)

Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies
por: Li, Chang, et al.
Publicado: (2018)

Differences in Vector Genome Processing and Illegitimate Integration of Non-Integrating Lentiviral Vectors
por: Shaw, Aaron M., et al.
Publicado: (2016)

Cell and Tissue Gene Targeting with Lentiviral Vectors
por: Escors, David, et al.
Publicado: (2012)

Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?
por: Deng, Longfei, et al.
Publicado: (2022)

Production of lentiviral vectors
por: Merten, Otto-Wilhelm, et al.
Publicado: (2016)

Lentiviral Vector Bioprocessing
por: Perry, Christopher, et al.
Publicado: (2021)

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
por: Castellani, Stefano, et al.
Publicado: (2010)

Development of lentiviral vectors for gene therapy of arthritis
por: Militello, M, et al.
Publicado: (2001)

Minimal impact of ZAP on lentiviral vector production and transduction efficiency
por: Sertkaya, Helin, et al.
Publicado: (2021)

Transcriptional Targeting and MicroRNA Regulation of Lentiviral Vectors
por: Merlin, Simone, et al.
Publicado: (2019)

Targeting lentiviral vectors to primordial germ cells (PGCs): An efficient strategy for generating transgenic chickens
por: Jiang, Zi-Qin, et al.
Publicado: (2020)

The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology
por: Apolonia, Luis
Publicado: (2020)

The feasibility of incorporating Vpx into lentiviral gene therapy vectors
por: McAllery, Samantha A, et al.
Publicado: (2016)

Gene Therapy Applications of Non-Human Lentiviral Vectors
por: Munis, Altar M.
Publicado: (2020)

Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
por: Poletti, Valentina, et al.
Publicado: (2021)

Toward lentiviral vectors for antiangiogenic ocular gene therapy
por: Askou, Anne Louise, et al.
Publicado: (2023)

High-efficiency transduction of spinal cord motor neurons by intrauterine delivery of integration-deficient lentiviral vectors
por: Ahmed, Sherif G., et al.
Publicado: (2018)

The Inside Out of Lentiviral Vectors
por: Durand, Stéphanie, et al.
Publicado: (2011)

Clinical use of lentiviral vectors
por: Milone, Michael C., et al.
Publicado: (2018)

Special Issue “Lentiviral Vectors”
por: Takeuchi, Yasuhiro
Publicado: (2022)

Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
por: Morante, Valeria, et al.
Publicado: (2021)

Influence of insulators on transgene expression from integrating and non-integrating lentiviral vectors
por: Grandchamp, Nicolas, et al.
Publicado: (2011)

Progresses towards safe and efficient gene therapy vectors
por: Chira, Sergiu, et al.
Publicado: (2015)

Production of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cells
por: Tai, April, et al.
Publicado: (2011)

Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8
por: Michels, Alexander, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6uj8dkjvo86b58cbsir1dkkauc